Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium

被引:101
作者
Knable, MB
Torrey, EF
Webster, MJ
Bartko, JJ
机构
[1] Stanley Fdn Res Programs, Bethesda, MD 20814 USA
[2] Uniformed Serv Univ Hlth Sci, Stanley Brain Res Lab, Bethesda, MD 20814 USA
关键词
schizophrenia; bipolar disorder; depression; neuropathology; postmortem;
D O I
10.1016/S0361-9230(01)00521-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Prefrontal cortical tissue from the Stanley Foundation Neuropathology Consortium, which contains samples from patients with schizophrenia, bipolar disorder, non-psychotic depression, and normal controls (n = 15 per group), was studied in a blinded fashion in 14 different laboratories between 1997 and 2000. The results of 69 separate data sets were analyzed with univariate and multivariate techniques. A total of 17 abnormal markers were identified that pertained to a variety of neural systems and processes, including neuronal plasticity, neurotransmission, signal transduction, inhibitory interneuron function, and glial cells. Schizophrenia was associated with the largest number of abnormalities, many of which were also present in bipolar disorder. Major depression was associated with relatively few abnormalities. The majority of abnormal findings represented a decline in function and could not be easily explained by exposure to psychotropic or illicit drugs. It is argued that the abnormal findings are not simply due to stochastic processes but represent viable markers for independent replication and further study as candidate genes or targets for new treatments. (C) 2001 Elsevier Science Inc.
引用
收藏
页码:651 / 659
页数:9
相关论文
共 41 条
[1]   GENE-EXPRESSION FOR GLUTAMIC-ACID DECARBOXYLASE IS REDUCED WITHOUT LOSS OF NEURONS IN PREFRONTAL CORTEX OF SCHIZOPHRENICS [J].
AKBARIAN, S ;
KIM, JJ ;
POTKIN, SG ;
HAGMAN, JO ;
TAFAZZOLI, A ;
BUNNEY, WE ;
JONES, EG .
ARCHIVES OF GENERAL PSYCHIATRY, 1995, 52 (04) :258-266
[2]   Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder [J].
Bayer, TA ;
Schramm, M ;
Feldmann, N ;
Knable, MB ;
Falkai, P .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2000, 24 (06) :881-888
[3]   A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania [J].
Bebchuk, JM ;
Arfken, CL ;
Dolan-Manji, S ;
Murphy, J ;
Hasanat, K ;
Manji, HK .
ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (01) :95-97
[4]   LITHIUM AMPLIFIES AGONIST-DEPENDENT PHOSPHATIDYLINOSITOL RESPONSES IN BRAIN AND SALIVARY-GLANDS [J].
BERRIDGE, MJ ;
DOWNES, CP ;
HANLEY, MR .
BIOCHEMICAL JOURNAL, 1982, 206 (03) :587-595
[5]  
Bolanos JP, 1997, J NEUROCHEM, V68, P2227
[6]   EXPRESSION OF WNT-1 IN PC12 CELLS RESULTS IN MODULATION OF PLAKOGLOBIN AND E-CADHERIN AND INCREASED CELLULAR ADHESION [J].
BRADLEY, RS ;
COWIN, P ;
BROWN, AMC .
JOURNAL OF CELL BIOLOGY, 1993, 123 (06) :1857-1865
[7]   Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder [J].
Caberlotto, L ;
Hurd, YL .
NEUROREPORT, 1999, 10 (08) :1747-1750
[8]   Identification of nuclear orphan receptors as regulators of expression of a neurotransmitter receptor gene [J].
Chew, LJ ;
Huang, F ;
Boutin, JM ;
Gallo, V .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (41) :29366-29375
[9]  
COHEN J, 1988, STAT POWER ANAL BEHA, P42
[10]   Abnormalities of Wnt signalling in schizophrenia - evidence for neurodevelopmental abnormality [J].
Cotter, D ;
Kerwin, R ;
Al-Sarraji, S ;
Brion, JP ;
Chadwich, A ;
Lovestone, S ;
Anderton, B ;
Everall, I .
NEUROREPORT, 1998, 9 (07) :1379-1383